Aurora Cannabis Acquires MedReleaf Australia

About this update from Aurora Cannabis Inc.

[{"type":"text","content":"\n \n \n \n Aurora Cannabis Acquires MedReleaf Australia\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prnrbrb0{\nBORDER-RIGHT:black 0pt\n}\n.prnml4{\nMARGIN-TOP:0em; MARGIN-RIGHT:0em; MARGIN-BOTTOM:0em; MARGIN-LEFT:0.33em !IMPORTANT\n}\n.prnsbbb0{\nBORDER-BOTTOM:black 0pt\n}\n.prnvab{\nVERTICAL-ALIGN: BOTTOM\n}\n.prnsbtb0{\nBORDER-TOP:black 0pt\n}\n.prntar{\nTEXT-ALIGN: RIGHT\n}\n.prnbcc{\nBORDER-COLLAPSE: COLLAPSE\n}\n.prnpr2{\nPADDING-RIGHT:0.17em\n}\n.prnsblb0{\nBORDER-LEFT:black 0pt\n}\n.prnpl2{\nPADDING-LEFT:0.17em\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n NASDAQ | TSX: ACB\n \n \n \n Aurora becomes the largest global medical cannabis company operating in nationally legal markets.\n \n \n MedReleaf Australia holds the #2 position in medical cannabis within the rapidly growing ~AUD$400 million\n \n 1\n \n Australian market.\n \n \n Transaction is expected to be immediately accretive to Adjusted EBITDA\n \n 2\n \n and accelerate the Company's plan for Positive Free Cash Flow\n \n 2\n \n generation in calendar 2024.\n \n \n \n \n \n EDMONTON, AB\n \n \n ,\n \n \n Feb. 8, 2024\n \n \n /CNW/ - Aurora Cannabis Inc. (the \"\n \n Company\n \n \" or \"\n \n Aurora\n \n \") (NASDAQ: ACB) (TSX: ACB), the\n \n Canada\n \n based leading global medical cannabis company, is pleased to announce that a wholly-owned subsidiary of the Company has acquired the remaining approximately 90% equity interest of Indica Industries Pty Ltd (\"\n \n MedReleaf Australia\n \n \") that Aurora did not previously own, at an enterprise value of AUD$50 million, subject to customary adjustments (the \"Transaction\"). Aurora paid AUD$9.45 million in cash with the balance of the purchase price satisfied by the issuance of common shares of Aurora (the \"\n \n Aurora Shares\n \n \").\n \n \n \n \n \n \n \n \n \n MedReleaf Australia\n \n is a leading distributor of medical cannabis\n \n \n products\n \n and holds the #2 position in the Australian medical cannabis market. This market is currently estimated to be worth approximately AUD$400 million\n \n 1\n \n and has quickly become one of the la...

More updates from Aurora Cannabis Inc.